CN Patent

CN107771074A — 可滴落眼科比马前列素凝胶

Assigned to Maid Paul Jate Pharmaceutical Development And Trade Co Ltd · Expires 2018-03-06 · 8y expired

What this patent protects

本发明涉及可滴落眼科凝胶，所述凝胶具有包含0.003至0.03重量％的比马前列素，＞0.2重量％的聚丙烯酸酯，0.2至10重量％的聚维酮(PVP)、葡聚糖、聚乙二醇(PEG)、羧甲基纤维素(CMC)或聚(乙烯醇)(PVA)，产生200至400mosml/kg的渗透压的量的等渗剂，0.05至0.4重量％的量的调节粘度的盐，调节pH到6至8的量的碱，和通常用于眼科凝胶的赋形剂的组合物，具有200至2000mPa.s范围的粘度。

USPTO Abstract

本发明涉及可滴落眼科凝胶，所述凝胶具有包含0.003至0.03重量％的比马前列素，＞0.2重量％的聚丙烯酸酯，0.2至10重量％的聚维酮(PVP)、葡聚糖、聚乙二醇(PEG)、羧甲基纤维素(CMC)或聚(乙烯醇)(PVA)，产生200至400mosml/kg的渗透压的量的等渗剂，0.05至0.4重量％的量的调节粘度的盐，调节pH到6至8的量的碱，和通常用于眼科凝胶的赋形剂的组合物，具有200至2000mPa.s范围的粘度。

Drugs covered by this patent

Patent Metadata

Patent number
CN107771074A
Jurisdiction
CN
Classification
—
Expires
2018-03-06
Drug substance claim
No
Drug product claim
No
Assignee
Maid Paul Jate Pharmaceutical Development And Trade Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.